Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 13-Jun-24 4:09 PM View:  | Vertex Pharmaceuticals Inc. (VRTX) | 12-Jun-24 | Sale (Planned) | 7,288 | $478.00 | $3,483,660.00 | (31%) 23.26K to 15.97K | |
| 13-Jun-24 4:09 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 11-Jun-24 | Payment of Exercise | 6,824 | $481.96 | $3,288,900.00 | (23%) 30.08K to 23.26K | |
| 16-May-24 4:12 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 14-May-24 | Grant | 14,112 | -- | -- | 88% 15.97K to 30.08K | |
| 27-Feb-24 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 26-Feb-24 | Sale (Planned) | 883 | $425.70 | $375,893.00 | (5%) 16.86K to 15.97K | |
| 27-Feb-24 4:44 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 23-Feb-24 | Payment of Exercise | 1,654 | $431.79 | $714,181.00 | (9%) 18.51K to 16.86K | |
| 23-Feb-24 4:16 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 21-Feb-24 | Private Sale (Planned) | 1,201 | $421.77 | $506,546.00 | (6%) 19.71K to 18.51K | |
| 21-Feb-24 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Payment of Exercise | 1,125 | $420.58 | $473,152.00 | (5%) 21.64K to 20.51K | |
| 21-Feb-24 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 20-Feb-24 | Sale (Planned) | 801 | $420.79 | $337,053.00 | (4%) 20.51K to 19.71K | |
| 21-Feb-24 4:23 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 16-Feb-24 | Payment of Exercise | 1,501 | $424.01 | $636,439.00 | (6%) 23.14K to 21.64K | |
| 13-Feb-24 4:54 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 12-Feb-24 | Sale (Planned) | 913 | $420.24 | $383,679.00 | (4%) 24.05K to 23.14K | |
| 13-Feb-24 4:54 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 09-Feb-24 | Payment of Exercise | 832 | $422.74 | $351,720.00 | (3%) 24.88K to 24.05K | |
| 08-Feb-24 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 07-Feb-24 | Grant | 4,743 | -- | -- | 24% 20.14K to 24.88K | |
| 08-Feb-24 4:24 PM View: | Vertex Pharmaceuticals Inc. (VRTX) | 06-Feb-24 | Grant | 6,260 | -- | -- | 45% 13.88K to 20.14K | |
| 05-Jun-23 5:03 PM View: | 89bio, Inc. (ETNB) | 01-Jun-23 | Option Exercise | 6,250 | $2.61 | $16,312.50 | 100% 0 to 6.25K | |
| 05-Jun-23 5:03 PM View: | 89bio, Inc. (ETNB) | 01-Jun-23 | Option Sale | 6,250 | $17.91 | $111,938.00 | (100%) 6.25K to 0 | |
| 03-Mar-23 5:18 PM View: | 89bio, Inc. (ETNB) | 01-Mar-23 | Option Exercise | 10,000 | $4.44 | $44,400.00 | 100% 0 to 10.0K | |
| 03-Mar-23 5:18 PM View: | 89bio, Inc. (ETNB) | 01-Mar-23 | Option Sale | 10,000 | $13.60 | $136,000.00 | (100%) 10.0K to 0 |